Profile and correlates of colorimetric reagent kit use among people who use ecstasy/MDMA and other illegal stimulants in Australia-Reference-Cited by-同舟云学术

Profile and correlates of colorimetric reagent kit use among people who use ecstasy/MDMA and other illegal stimulants in Australia

Published:2021-11 Issue: Volume:97 Page:103334
ISSN:0955-3959
Container-title:International Journal of Drug Policy
language:en
Short-container-title:International Journal of Drug Policy

Author:

Peacock Amy,Gibbs Daisy,Price Olivia,Barratt Monica J.,Ezard Nadine,Sutherland Rachel,Hill Penelope L.,Grigg Jodie,Lenton Simon,Page Robert,Salom Caroline,Hughes Caitlin,Bruno Raimondo

Publisher

Elsevier BV

Subject

Health Policy,Medicine (miscellaneous)

Reference36 articles.

1. National Drug Strategy Household Survey 2019,2020

2. Trusting the source: The potential role of drug dealers in reducing drug-related harms via drug checking;Bardwell;Drug and Alcohol Dependence,2019

3. Global Review of Drug Checking Services Operating in 2017;Barratt,2018

4. Global review of drug checking services operating in 2017;Barratt,2018

5. Urine drug screening for early detection of unwitting use of fentanyl and its analogues among people who inject heroin in Sydney;Barratt;Australia,2018

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A thematic analysis of MDMA-related harm and harm reduction experiences and knowledge in Aotearoa New Zealand;Harm Reduction Journal;2024-05-23

2. Harm reduction behaviours and harm experiences of people who use 3,4-methylenedioxymethamphetamine (MDMA) in Aotearoa New Zealand;Harm Reduction Journal;2024-03-21

3. Adulteration and substitution of drugs purchased in Australia from cryptomarkets: An analysis of Test4Pay;Drug and Alcohol Review;2024-03-04

4. Increases in the use of drug testing kits among nightclub and festival attendees in New York City who use ecstasy, 2017–2022;Drug and Alcohol Review;2024-02-26

5. A Scoping Review of Australian Literature on People Who Use MDMA and Their Harm Reduction Practices;Contemporary Drug Problems;2023-11-15